Condensed Consolidated Statements of Stockholders' Equity - USD ($) shares in Thousands, $ in Thousands	Total	Common Stock	Additional Paid-In Capital	Retained Deficit	Accumulated Other Comprehensive Loss	Treasury Stock
Beginning balance (in shares) at Dec. 31, 2024		43,432
Beginning balance at Dec. 31, 2024	$ 276,200	$ 434	$ 376,607	$ (61,266)	$ (24,927)	$ (14,648)
Beginning balance, treasury stock (in shares) at Dec. 31, 2024						(1,487)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	(505)			(505)
Other comprehensive income (loss), net of tax	6,331				6,331
Equity compensation (in shares)		543
Equity compensation	8,045	$ 6	8,039
Exercise of options (in shares)		171
Exercise of options	3,220	$ 2	3,218
Employee stock purchase plan (in shares)		44
Employee stock purchase plan	961		961
Ending balance (in shares) at Mar. 31, 2025		44,190
Ending balance at Mar. 31, 2025	294,252	$ 442	388,825	(61,771)	(18,596)	$ (14,648)
Ending balance, treasury stock (in shares) at Mar. 31, 2025						(1,487)
Beginning balance (in shares) at Dec. 31, 2025		49,330
Beginning balance at Dec. 31, 2025	$ 448,232	$ 493	516,604	(51,498)	(2,719)	$ (14,648)
Beginning balance, treasury stock (in shares) at Dec. 31, 2025	(1,487)					(1,487)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	$ 1,417			1,417
Other comprehensive income (loss), net of tax	(8,846)				(8,846)
Equity compensation (in shares)		603
Equity compensation	8,414	$ 6	8,408
Exercise of options (in shares)		9
Exercise of options	178		178
Employee stock purchase plan (in shares)		41
Employee stock purchase plan	1,072	$ 1	1,071
Ending balance (in shares) at Mar. 31, 2026		49,983
Ending balance at Mar. 31, 2026	$ 450,467	$ 500	$ 526,261	$ (50,081)	$ (11,565)	$ (14,648)
Ending balance, treasury stock (in shares) at Mar. 31, 2026	(1,487)					(1,487)